Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
JTEC Corp/Osaka (3446 JP)
Watchlist
14
Analysis
Health Care
•
Japan
JTEC Corporation of Osaka manufactures bio-technology systems and equipment. The Company produces life science devices, x ray mirrors, and automated cell culture systems. JTEC also develops pharmaceutical products. JTEC serves clients in Japan.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JTEC Corp/Osaka
•
28 May 2026 07:51
•
Issuer-paid
JTEC Corp (3446 JP) - Optical Keeps Strong Momentum, and Semiconductor Is Poised to Deliver
Although the cumulative revenue run rate stands at 39.2% of the FY target, the company maintains its FY6/26 outlook, relying on its back-loaded...
Astris Advisory Japan
Follow
83 Views
Share
bullish
•
JTEC Corp/Osaka
•
27 Feb 2026 08:42
•
Issuer-paid
JTEC Corp (3446 JP) - Strength in Optical Remains, and AI Is Stimulating Traction in Semiconductor
While the run rate for FY6/26 remains behind schedule (FY revenue run rate of 24.5%), JTEC saw a notable YoY recovery (sales +14.5%) in H1, and OP...
Astris Advisory Japan
Follow
118 Views
Share
bullish
•
JTEC Corp/Osaka
•
05 Dec 2025 04:55
•
Issuer-paid
JTEC Corp (3446 JP) - Strength in Optical Remains, Progress in Semiconductor
A soft start – Q1 FY6/26 results were relatively soft, with sales flat and OP still in negative territory. This reflects the seasonally weak nature...
Astris Advisory Japan
Follow
275 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2026 09:41
•
Issuer-paid
Annual Directory: Corporate Research - January 2026
This inaugural edition of the Astris Advisory Japan Annual Directory presents our corporate equity research coverage to support informed decision...
Astris Advisory Japan
Follow
136 Views
Share
bullish
•
JTEC Corp/Osaka
•
17 May 2025 10:13
•
Issuer-paid
JTEC Corp (3446 JP) - Continued Uplift in Performance
The company has maintained FY6/25 guidance, and while this implies a back-end-loaded Q4 FY6/25, order visibility appears firm from demand on a...
Astris Advisory Japan
Follow
601 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x